Battling a Receding Tide: Treatment for Androgenic Alopecia
November 2025
in “
Australian Journal of General Practice
”
Studysummary This source discusses the aim of the Australian Journal of General Practice to deliver evidence-based information to help Australian general practitioners provide optimal patient care. Results from specific studies are not included.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The case study discusses a 36-year-old man with androgenic alopecia, highlighting treatment options and considerations. A trial with 428 men showed that oral finasteride led to hair regrowth in 80.5% of patients, topical minoxidil in 59.0%, and combined treatment in 94.1% after 12 months. First-line treatments for mild-to-moderate cases include minoxidil or finasteride, with combination therapy for severe cases. Minoxidil can cause dermatitis and hypertrichosis, while finasteride may lead to sexual dysfunction and psychological effects. Finasteride also affects fertility, making minoxidil a better option for those planning to conceive. The patient chose not to use finasteride to preserve fertility.
